Price Alert

InterCure Ltd. (INCR)

NASDAQ: INCR · Real-Time Price · USD

1.66

0.00 (0.00%)

At close: Aug 15, 2025, 12:28 PM

InterCure Income Statement

Financials in ILS. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	238.85M	255.76M	272.67M	312.25M	355.55M	387.69M	414.79M	407.63M	388.68M	362.78M	323.9M	273.86M	219.68M	167.07M	127.87M	93.83M
Cost of Revenue	196.8M	195.75M	194.7M	222.46M	252.27M	256.59M	255.64M	237.49M	213.49M	199.19M	184.47M	158.1M	128.54M	96.69M	68.29M	48.7M
Gross Profit	42.05M	60.01M	77.98M	89.79M	103.28M	110.99M	139.04M	150.03M	155.08M	163.59M	139.43M	115.75M	90.53M	69.78M	58.98M	44.53M
Operating Income	-67.21M	-55.01M	-42.82M	-42.26M	-41.57M	-18.37M	24.48M	36.59M	50.63M	63.15M	51.51M	42.46M	28.19M	26.59M	24.43M	14.7M
Interest Income	n/a	8.01M	16.01M	16.73M	18.26M	12M	4.16M	3.44M	3.62M	1.87M	1.71M	1.71M	n/a	n/a	59K	71K
Pretax Income	-87.32M	-74.66M	-61.99M	-62.32M	-61.28M	-38.28M	5.4M	26.21M	43.84M	55.13M	45.26M	32.52M	18.74M	23.86M	23.98M	14.53M
Net Income	-67.8M	-66.71M	-65.62M	-61.46M	-61.96M	-19.88M	20.9M	31.66M	44.82M	33.2M	24.3M	14.85M	4.69M	16.98M	20.36M	13.19M
Selling & General & Admin	110.18M	101.57M	92.97M	95.54M	98.47M	98.3M	105.82M	104.52M	97.32M	96.16M	80.94M	67.58M	57.45M	42.34M	34.19M	29M
Research & Development	414K	382.5K	351K	340.5K	388K	496K	550K	627K	632K	678K	856K	1.04M	1.24M	1.36M	1.51M	1.56M
Other Expenses	-1.33M	13.07M	27.48M	35.27M	45.1M	27.77M	6.24M	6.24M	4.2M	2.93M	2.93M	2.93M	2.93M	745K	745K	745K
Operating Expenses	109.26M	115.03M	132.98M	143.33M	156.14M	150.47M	124.34M	123.11M	113.88M	96.27M	81.22M	68.05M	58.1M	44.44M	36.44M	31.31M
Interest Expense	n/a	n/a	n/a	6.14M	11.84M	16.04M	20.43M	19.81M	16.4M	12.21M	10.28M	4.76M	2.55M	2.55M	330K	473K
Selling & Marketing Expenses	54.23M	53.58M	52.92M	53.43M	53.27M	19.96M	24M	24.05M	20.31M	49.43M	38.9M	29.48M	23.21M	17.73M	13.98M	10.89M
Cost & Expenses	306.05M	310.77M	327.68M	365.79M	406.37M	415.31M	388.22M	368.85M	337.65M	299.23M	269.47M	229.92M	190.26M	140.97M	104.57M	79.85M
Income Tax Expense	17.49M	11.43M	5.37M	1.31M	2.25M	-13.69M	-11.99M	-2.93M	93K	19.68M	17.58M	14.38M	11.44M	3.3M	2.04M	-497K
Shares Outstanding (Basic)	43.91M	43.91M	47.77M	47.77M	44.8M	44.8M	42.8M	42.8M	45.35M	45.35M	45.99M	37.15M	39.08M	41.1M	44.23M	27.02M
Shares Outstanding (Diluted)	43.97M	43.97M	47.77M	47.77M	44.81M	44.81M	42.8M	42.8M	45.35M	45.35M	45.99M	37.15M	42.64M	41.1M	51.6M	27.02M
EPS (Basic)	-1.55	-1.51	-1.47	-1.37	-1.39	-0.52	0.39	0.62	0.98	0.78	0.58	0.38	0.05	0.49	0.60	0.42
EPS (Diluted)	-1.55	-1.51	-1.47	-1.37	-1.39	-0.52	0.39	0.62	0.98	0.79	0.59	0.37	0.03	0.46	0.57	0.41
EBITDA	-79.33M	-37.24M	5.04M	6.85M	10.3M	14.72M	38.45M	56.16M	69.56M	76.53M	63.8M	46.74M	29.65M	31.56M	30.14M	19.98M
EBIT	-87.89M	-45.43M	-2.97M	-1.59M	737K	2.85M	25.83M	46.02M	60.24M	68.35M	56.55M	38.24M	22.26M	26.31M	25.19M	15.87M
Depreciation & Amortization	8.55M	8.18M	8.01M	9.14M	10.27M	12.57M	13.42M	12.52M	11.7M	8.28M	7.24M	6.22M	5.12M	5.26M	4.95M	4.11M